| Code | CSB-MP003996HU |
| Abbreviation | Recombinant Human C5AR1 protein-VLPs (Active) |
| MSDS | |
| Size | $620 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
C5AR1 (CD88) is a seven-transmembrane GPCR central to complement-mediated inflammation and increasingly implicated in tumor immune evasion, making conformationally intact protein a critical tool for cancer-focused drug discovery. This recombinant human C5AR1 presents the full-length receptor (aa 1–350) displayed on virus-like particles produced in mammalian cells, preserving the native membrane topology and post-translational modifications that soluble fragments cannot replicate. Functional ELISA confirms binding to an anti-C5AR1 recombinant antibody with an EC50 of 1.239–3.760 ng/mL, providing a validated basis for ligand-receptor interaction assays, competitive blocking antibody screening, therapeutic antibody epitope mapping, and small-molecule inhibitor discovery campaigns. Endotoxin levels below 1.0 EU/μg, determined by LAL, satisfy the criteria typical for cell-based assays and sensitive binding platforms such as SPR and BLI, where the VLP format supports use as a positive control for affinity characterization studies.
Applications : Binding assay/Protein-protein interaction
Review: I used the CSB-MP003996HU protein for an ELISA experiment, and the EC50 was measured to be 0.8830-2.771 ng/ml, indicating good protein activity. In the subsequent antibody screening, we employed flow cytometric analysis to determine whether this protein can bind to molecules expressed on the cell surface. The results showed that some antibodies were able to bind to this protein. The protein quality is quite good.
By Anonymous